Warfarin vs. Pradaxa

See how Warfarin and Pradaxa compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Warfarin requires regular INR blood tests and a steady vitamin K intake, while Pradaxa is taken at a fixed dose without routine coagulation monitoring.

  • Brand-name Pradaxa costs far more out of pocket than warfarin, which is one of the least expensive oral anticoagulants available.

  • Both drugs increase bleeding risk, but warfarin's effects can be reversed with vitamin K while Pradaxa has its own dedicated reversal agent for emergencies.

Warfarin vs. Pradaxa Drug Summary

Warfarin

Warfarin is a vitamin K antagonist that prevents and treats blood clots, including deep vein thrombosis, pulmonary embolism, and clot-related strokes from atrial fibrillation or heart valve replacement. It is taken as a once-daily tablet, with the dose adjusted based on regular INR blood tests.

Pradaxa

Pradaxa (dabigatran) is a direct thrombin inhibitor that lowers stroke risk in people with nonvalvular atrial fibrillation and treats or prevents blood clots such as DVT and PE. It is taken as a fixed-dose capsule, usually twice daily, without routine blood test monitoring.

Warfarin vs. Pradaxa Side Effects

Warfarin

Most common
Hemorrhage (not specified)
Necrosis (not specified)
Calciphylaxis (not specified)
Vasculitis (not specified)

Pradaxa

Most common
GI reactions (up to 35%)
Dyspepsia (up to 7.5%)
GI bleeding (up to 6.6%)
Gastritis-like (up to 3.0%)

Warfarin vs. Pradaxa Dosage

Warfarin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2 mg to 5 mg once daily Days 1-4
Maximum dose 2 mg to 10 mg once daily Day 5 onward
Dose changes 1 increase Every 4 days

Pradaxa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 150 mg twice daily At the start
Maximum dose 220 mg once daily Days 2-35
Dose changes 3 increases Every day

Warfarin vs. Pradaxa Indications

Warfarin

Warfarin prevents and treats blood clots in the veins and lungs, and lowers the risk of stroke from atrial fibrillation or mechanical heart valves. It is also used after a heart attack to reduce the risk of death, another heart attack, or stroke.

  • Treats and prevents deep vein thrombosis and pulmonary embolism

  • Prevents stroke and clots from atrial fibrillation

  • Prevents clots after mechanical heart valve replacement

  • Reduces risk of death and recurrent event after a heart attack

Pradaxa

Pradaxa lowers the risk of stroke and blood clots in people with nonvalvular atrial fibrillation. It also treats deep vein thrombosis and pulmonary embolism, helps prevent their recurrence, and prevents clots after hip replacement surgery.

  • Lowers stroke and systemic embolism risk in nonvalvular AFib

  • Treats deep vein thrombosis and pulmonary embolism

  • Reduces risk of DVT or PE recurrence after initial treatment

  • Prevents blood clots after hip replacement surgery

Warfarin vs. Pradaxa Pros and Cons

Warfarin

Warfarin has decades of real-world use and is one of the least expensive oral anticoagulants, but it demands regular blood testing and careful attention to diet and drug interactions. Coverage is nearly universal since it has been a generic staple for decades.

Pros

  • Typically $4 to $35 per month without insurance

  • Long track record of use since 1954, well understood by prescribers

  • Bleeding effects can be reversed with vitamin K

  • Only oral anticoagulant approved for mechanical heart valve patients

Cons

  • Requires regular INR blood tests and dose adjustments

  • Effectiveness is affected by diet, alcohol, and many medications

  • Narrow therapeutic window raises risk of under- or over-anticoagulation

Pradaxa

Pradaxa offers fixed dosing without routine blood test monitoring, but brand-name pricing runs much higher than warfarin's generic tablets. It is generally covered by insurance, though generic dabigatran can bring the cost down.

Pros

  • Fixed dosing without need for routine blood monitoring

  • Fewer food and drug interactions than warfarin

  • Specific reversal agent (idarucizumab) available for emergencies

  • Lower risk of intracranial bleeding than warfarin in clinical trials

Cons

  • Brand-name cost roughly $400 to $530 per month, before savings programs

  • Higher rate of GI side effects like dyspepsia and stomach upset

  • Requires dose adjustment or avoidance with significant kidney impairment

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.